Further delineation of the clinical spectrum of de novo TRIM8 truncating mutations
- 1 November 2018
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 176 (11), 2470-2478
- https://doi.org/10.1002/ajmg.a.40357
Abstract
De novo mutations of the TRIM8 gene, which codes for a tripartite motif protein, have been identified using whole exome sequencing (WES) in two patients with epileptic encephalopathy (EE), but these reports were not sufficient to conclude that TRIM8 was a novel gene responsible for EE. Here we report four additional patients presenting with EE and de novo truncating mutations of TRIM8 detected by WES, and give further details of the patient previously reported by the Epi4K consortium. Epilepsy of variable severity was diagnosed in children aged 2 months to 3.5 years of age. All patients had developmental delay of variable severity with no or very limited language, often associated with behavioral anomalies and unspecific facial features or MRI brain abnormalities. The phenotypic variability observed in these patients appeared related to the severity of the epilepsy. One patient presented pharmacoresistant EE with regression, recurrent infections and nephrotic syndrome, compatible with the brain and kidney expression of TRIM8. Interestingly, all mutations were located at the highly conserved C-terminus section of TRIM8. This collaborative study confirms that TRIM8 is a novel gene responsible for EE, possibly associated with nephrotic syndrome. This report brings new evidence on the pathogenicity of TRIM8 mutations and highlights the value of data-sharing to delineate the phenotypic characteristics and biological basis of extremely rare disorders.Funding Information
- National Institute of Neurological Disorders and Stroke
This publication has 36 references indexed in Scilit:
- Loss-of-Function Mutations in WDR73 Are Responsible for Microcephaly and Steroid-Resistant Nephrotic Syndrome: Galloway-Mowat SyndromeAmerican Journal of Human Genetics, 2014
- Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndromeAmerican Journal of Medical Genetics Part A, 2014
- De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic EncephalopathiesAmerican Journal of Human Genetics, 2014
- TRIM8 anti-proliferative action against chemo-resistant renal cell carcinomaOncotarget, 2014
- De novo mutations in epileptic encephalopathiesNature, 2013
- Trim24 targets endogenous p53 for degradationProceedings of the National Academy of Sciences of the United States of America, 2009
- Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegenerationProceedings of the National Academy of Sciences of the United States of America, 2008
- PML enhances the regulation of p53 by CK1 in response to DNA damageOncogene, 2008
- Limb-Girdle Muscular Dystrophy Type 2H Associated with Mutation in TRIM32, a Putative E3-Ubiquitin–Ligase GeneAmerican Journal of Human Genetics, 2002
- Diagnostic dilemmas in four infants with nephrotic syndrome, microcephaly and severe developmental delayClinical Dysmorphology, 2001